The role of broad spectrum antibiotics in the emergence of hospitalized infections
Abstract
Hospitalized infections have not yet been resolved as a global medical problem in all clinics around the world. Thus, hospitalized infections, while aggravating the course of the disease, reduce the efficacy of the treatment and increase the number of hospital beds for the patients, which leads to the increase in financial costs. resulting in a lot of time.
References
Boucher HW, Talbot GH, Benjamin DK, Jr, et al. 10 x ‘20 Progress–Development of New Drugs Active Against Gram-negative Bacilli: An Update from the Infectious Diseases Society of America. Clin Infect Dis. 2013;56(12):1685–94.
(a) Jabes D. The antibiotic R&D Pipeline: An Update. Curr Opin in Microbiol. 2011;14(5):564–9.
Moellering RC. Discovering New Antimicrobial Agents. Int J Antimicrob Agents. 2011;37(1):2–9.
WHO: Department of Communicable Disease Surveillance and Response WHO Global Strategy for Containment of Antimicrobial Resistance. [Accessed: December 20, 2013]. Available at: http://www.who.int/csr/resources/publications/drugresist/en/EGlobal_Strat.pdf.
European Centre for Disease Prevention and Control Communication from the Commission to the European Parliament and the Council. Action plan against the rising threats from Antimicrobial Resistance. [Accessed: December 20, 2013]. Available at: http://ec.europa.eu/dgs/health_consumer/docs/communication_amr_2011_748_en.pdf.
Nathan C. Antibiotics at the Crossroads. Nature. 2004;431(7011):899–902.
Keywords
infections
etiological factors
antiseptics
disinfectants Назокоминал
инфекции
этиологические факторы
антисептики
дезинфицирующие средства Nazokominal
infeksiyalar
etioloji amillər
antiseptiklər
dezinfektantlar